All Stories

  1. ClonoSEQ assay for the detection of lymphoid malignancies

    Article • Expert Review of Molecular Diagnostics, June 2019, Taylor & Francis

    Josep Nomdedeu

  2. Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy

    Article • Clinical Lymphoma Myeloma & Leukemia, November 2018, Elsevier

    Josep Nomdedeu

  3. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia

    Article • Cytometry Part B Clinical Cytometry, October 2018, Wiley

    Josep Nomdedeu

  4. An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens

    Article • Leukemia & Lymphoma, October 2018, Taylor & Francis

    Josep Nomdedeu, Professor Josep-Maria Ribera

  5. A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia

    Article • Leukemia & Lymphoma, February 2018, Taylor & Francis

    Josep Nomdedeu, Alfons Navarro, Mireia Camós Guijosa

  6. Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival

    Article • Leukemia & Lymphoma, January 2018, Taylor & Francis

    Professor Josep-Maria Ribera, Josep Nomdedeu

  7. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

    Article • Cytometry Part B Clinical Cytometry, January 2018, Wiley

    Dr Gian Matteo Rigolin, Josep Nomdedeu

  8. Bone Marrow WT1 Levels in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplasia: Clinically Relevant Time Points and 100 Copies Threshold Value

    Article • Biology of Blood and Marrow Transplantation, January 2018, Elsevier

    Josep Nomdedeu

  9. NEDD9, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients

    Article • Oncotarget, June 2017, Impact Journals, LLC

    Josep Nomdedeu

  10. Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes

    Article • Stem Cell Reports, June 2017, Elsevier

    Dr Eduardo Anguita, Josep Nomdedeu

  11. FcγRIIb expression in early stage chronic lymphocytic leukemia

    Article • Leukemia & Lymphoma, April 2017, Taylor & Francis

    Josep Nomdedeu

  12. Epigenetic loss of the RNA decapping enzyme NUDT16 mediates C-MYC activation in T-cell acute lymphoblastic leukemia

    Article • Leukemia, March 2017, Springer Science + Business Media

    Josep Nomdedeu

  13. Erytrocyte-related phenotypes and genetic susceptibility to thrombosis

    Article • Blood Cells Molecules and Diseases, July 2016, Elsevier

    Josep Nomdedeu

  14. Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach

    Article • Hematological Oncology, May 2016, Wiley

    Josep Nomdedeu, FRANCESC SOLE

  15. Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies

    Article • Blood, April 2016, American Society of Hematology

    Josep Nomdedeu

  16. A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

    Article • Leukemia, December 2015, Springer Science + Business Media

    Josep Nomdedeu

  17. The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia

    Article • Blood Cancer Journal, October 2015, Springer Science + Business Media

    Josep Nomdedeu

  18. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature

    Article • Oncotarget, September 2015, Impact Journals, LLC

    Josep Nomdedeu

  19. Complex Measurements May Be Required to Establish the Prognostic Impact of Immunophenotypic Markers in AML

    Article • American Journal of Clinical Pathology, September 2015, Oxford University Press (OUP)

    Josep Nomdedeu

  20. Genetic determinants of Platelet Large-Cell Ratio, Immature Platelet Fraction, and other platelet-related phenotypes

    Article • Thrombosis Research, August 2015, Elsevier

    Josep Nomdedeu

  21. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols

    Article • Cancer, July 2015, Wiley

    Professor Josep-Maria Ribera, Josep Nomdedeu, FRANCESC SOLE

  22. A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR

    Article • Leukemia, July 2014, Springer Science + Business Media

    Josep Nomdedeu

  23. Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1

    Article • Annals of Hematology, May 2014, Springer Science + Business Media

    Josep Nomdedeu

  24. MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia

    Article • Leukemia, September 2013, Springer Science + Business Media

    Josep Nomdedeu

  25. Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease

    Article • European Journal Of Haematology, July 2013, Wiley

    Josep Nomdedeu

  26. Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia

    Article • Blood, May 2013, American Society of Hematology

    Josep Nomdedeu

  27. Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML

    Article • Leukemia, April 2013, Springer Science + Business Media

    Josep Nomdedeu

  28. Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy

    Article • Blood, February 2013, American Society of Hematology

    Josep Nomdedeu

  29. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

    Article • Blood, December 2012, American Society of Hematology

    Dr Francesco Bertoni, Josep Nomdedeu

  30. Genome-wide DNA methylation profiling predicts relapse in childhood B-cell acute lymphoblastic leukaemia

    Article • British Journal of Haematology, October 2012, Wiley

    Josep Nomdedeu

  31. Adverse impact of IDH1 and IDH2 mutations in primary AML: Experience of the Spanish CETLAM group

    Article • Leukemia Research, August 2012, Elsevier

    Josep Nomdedeu

  32. Subcutaneous passage increases cell aggressiveness in a xenograft model of diffuse large B cell lymphoma

    Article • Clinical & Experimental Metastasis, January 2012, Springer Science + Business Media

    Josep Nomdedeu

  33. Influence of Age, Gender and Lifestyle in Lymphocyte Subsets: Report from the Spanish Gait-2 Study

    Article • Acta Haematologica, January 2012, Karger Publishers

    Josep Nomdedeu

  34. Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca

    Article • Journal of Clinical Psychopharmacology, December 2011, Wolters Kluwer Health

    Dr Rafael G Dos Santos, Josep Nomdedeu

  35. E-box-independent regulation of transcription and differentiation by MYC

    Article • Nature Cell Biology, October 2011, Springer Science + Business Media

    Josep Nomdedeu

  36. Pharmacology of ayahuasca administered in two repeated doses

    Article • Psychopharmacology, August 2011, Springer Science + Business Media

    Dr Rafael G Dos Santos, Josep Nomdedeu

  37. Immunophenotype distinction between acute promyelocytic leukaemia and CD15− CD34− HLA-DR− acute myeloid leukaemia with nucleophosmin mutations

    Article • Hematological Oncology, August 2011, Wiley

    Josep Nomdedeu

  38. Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion

    Article • Annals of Oncology, June 2011, Oxford University Press (OUP)

    Dr Francesco Bertoni, Josep Nomdedeu, Prof. Emanuele Zucca

  39. Rituximab treatment may disturb the normal pattern of lymphopoiesis after cord blood SCT

    Article • Bone Marrow Transplantation, May 2011, Springer Science + Business Media

    Josep Nomdedeu

  40. Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome

    Article • Hematological Oncology, March 2011, Wiley

    Dr Francesco Bertoni, Josep Nomdedeu, Prof. Emanuele Zucca

  41. Immunophenotype of acute myeloid leukemia with NPM mutations: Prognostic impact of the leukemic compartment size

    Article • Leukemia Research, February 2011, Elsevier

    Josep Nomdedeu

  42. The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia

    Article • Cancer Cell, September 2010, Elsevier

    Josep Nomdedeu

  43. Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21

    Article • British Journal of Haematology, August 2010, Wiley

    Dr Francesco Bertoni, Josep Nomdedeu, Prof. Emanuele Zucca

  44. WT1 monitoring in core binding factor AML: Comparison with specific chimeric products

    Article • Leukemia Research, December 2009, Elsevier

    Josep Nomdedeu

  45. Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by StandardizedWT1Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study

    Article • Journal of Clinical Oncology, November 2009, American Society of Clinical Oncology (ASCO)

    Josep Nomdedeu

  46. Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome

    Article • Clinical Cancer Research, June 2009, American Association for Cancer Research (AACR)

    Dr Francesco Bertoni, Josep Nomdedeu, Prof. Emanuele Zucca

  47. Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate

    Article • British Journal of Haematology, June 2009, Wiley

    Josep Nomdedeu

  48. The use of tetradecanoylphorbol acetate-stimulated peripheral blood cells enhances the prognostic value of interphase fluorescence in situ hybridization in patients with chronic lymphocytic leukemia

    Article • Genes Chromosomes and Cancer, January 2009, Wiley

    Josep Nomdedeu

  49. CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy

    Article • Leukemia, December 2008, Springer Science + Business Media

    Josep Nomdedeu, Dr Albert Oriol

  50. Novel IGHα translocations, t(2;14)(q14.3;q32) and t(14;17)(q32;q21), in B-cell precursor acute lymphoblastic leukemia

    Article • Cancer Genetics and Cytogenetics, August 2008, Elsevier

    Josep Nomdedeu

  51. K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML)

    Article • Annals of Hematology, June 2008, Springer Science + Business Media

    Josep Nomdedeu

  52. Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias

    Article • Leukemia Research, June 2008, Elsevier

    Josep Nomdedeu

  53. Severe and recurrent episodes of bronchiolitis obliterans organising pneumonia associated with indolent CD4+ CD8+ T-cell leukaemia

    Article • European Respiratory Journal, March 2008, European Respiratory Society (ERS)

    Josep Nomdedeu

  54. A celecoxib derivative inhibits focal adhesion signaling and induces caspase-8-dependent apoptosis in human acute myeloid leukemia cells

    Article • International Journal of Cancer, January 2008, Wiley

    Josep Nomdedeu

  55. Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype

    Article • Leukemia & Lymphoma, January 2008, Taylor & Francis

    Josep Nomdedeu

  56. Microsatellite instability may involve the pentanucleotide repeat of the PIG3 promoter in bcr/abl acute lymphoblastic leukemia

    Article • Leukemia Research, January 2008, Elsevier

    Josep Nomdedeu

  57. High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias

    Article • Annals of Hematology, October 2007, Springer Science + Business Media

    Josep Nomdedeu

  58. A large exon 6 break in V-form acute promyelocytic leukemia: relevance to clinical management

    Article • Leukemia, June 2007, Springer Science + Business Media

    Josep Nomdedeu

  59. Role of the Polycomb Repressive Complex 2 in Acute Promyelocytic Leukemia

    Article • Cancer Cell, June 2007, Elsevier

    Josep Nomdedeu

  60. Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies

    Article • Leukemia, May 2007, Springer Science + Business Media

    Josep Nomdedeu

  61. The V617F mutation of JAK2 is very uncommon in patients with thrombosis

    Article • Haematologica, February 2007, Ferrata Storti Foundation (Haematologica)

    Josep Nomdedeu

  62. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia

    Article • Cytometry Part B Clinical Cytometry, January 2007, Wiley

    Josep Nomdedeu

  63. Valoración de la mutación V617F del gen JAK2 en síndromes mieloproliferativos crónicos con cromosoma Filadelfia negativo

    Article • Medicina Clínica, October 2006, Elsevier

    Josep Nomdedeu

  64. Gene Expression Profiling of Acute Myeloid Leukemia with Translocation t(8;16)(p11;p13) and MYST3-CREBBP Rearrangement Reveals a Distinctive Signature with a Specific Pattern of HOX Gene Expression

    Article • Cancer Research, July 2006, American Association for Cancer Research (AACR)

    Josep Nomdedeu

  65. Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia

    Article • Blood, June 2006, American Society of Hematology

    Josep Nomdedeu

  66. Novel triiodophenol derivatives induce caspase-independent mitochondrial cell death in leukemia cells inhibited by Myc

    Article • Molecular Cancer Therapeutics, May 2006, American Association for Cancer Research (AACR)

    Josep Nomdedeu

  67. Acute Myeloid Leukemia Subgroups Identified by Pathway-Restricted Gene Expression Signatures

    Article • Acta Haematologica, January 2006, Karger Publishers

    Josep Nomdedeu

  68. Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]

    Article • Leukemia, November 2005, Springer Science + Business Media

    Josep Nomdedeu

  69. Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients

    Article • Leukemia Research, October 2005, Elsevier

    Josep Nomdedeu

  70. Peripheral T-Cell Lymphoma with Secondary Epithelioid Granulomatous Cutaneous Involvement: A Clinicopathologic Study of Four Cases

    Article • The Journal of Dermatology, July 2005, Wiley

    Josep Nomdedeu

  71. Allogeneic Stem-Cell Transplantation May Overcome the Adverse Prognosis of UnmutatedVHGene in Patients With Chronic Lymphocytic Leukemia

    Article • Journal of Clinical Oncology, May 2005, American Society of Clinical Oncology (ASCO)

    Josep Nomdedeu

  72. Microsatellite instability is not an uncommon finding in adult de novo acute myeloid leukemia

    Article • Annals of Hematology, March 2005, Springer Science + Business Media

    Josep Nomdedeu

  73. Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL)

    Article • Histopathology, September 2004, Wiley

    Josep Nomdedeu

  74. Quantitative Assessment of PML-RARa and BCR-ABL by Two Real-Time PCR Instruments: Multiinstitutional Laboratory Trial

    Article • Clinical Chemistry, June 2004, AACC

    Josep Nomdedeu

  75. MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemias

    Article • Leukemia, April 2004, Springer Science + Business Media

    Josep Nomdedeu

  76. Loss of heterozygosity of the polymorphic PIG3 microsatellite with low frequency in de novo acute myeloid leukemias

    Article • Leukemia, April 2004, Springer Science + Business Media

    Josep Nomdedeu

  77. FLT3 mutations are associated with other molecular lesions in AML

    Article • Leukemia Research, January 2004, Elsevier

    Josep Nomdedeu

  78. Eosinophilic Gastroenteritis or Eosinophilic Chloroma?

    Article • Acta Haematologica, January 2004, Karger Publishers

    Josep Nomdedeu

  79. Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone

    Article • Blood, October 2003, American Society of Hematology

    Josep Nomdedeu

  80. Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14

    Article • Journal of Clinical Pathology, October 2003, BMJ

    Josep Nomdedeu

  81. Cryptic t(5;11)(q35;p15.5) in adult de novo acute myelocytic leukemia with normal karyotype

    Article • Cancer Genetics and Cytogenetics, September 2003, Elsevier

    Josep Nomdedeu

  82. MLL tandem duplication in two cases of acute myelocytic leukemia with unbalanced translocations

    Article • Cancer Genetics and Cytogenetics, April 2003, Elsevier

    Josep Nomdedeu

  83. Childhood T-acute Lymphoblastic Leukemia Relapsed as Minimally Differentiated Acute Myeloid Leukemia (AML-M0)

    Article • Leukemia & Lymphoma, January 2003, Taylor & Francis

    Josep Nomdedeu

  84. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells

    Article • Leukemia, January 2003, Springer Science + Business Media

    Josep Nomdedeu

  85. ETO sequence may be dispensable in some AML1-ETO leukemias

    Article • Blood, December 2002, American Society of Hematology

    Josep Nomdedeu

  86. AML-1 mutations outside the RUNT domain: description of two cases in myeloid malignancies

    Article • Leukemia, October 2002, Springer Science + Business Media

    Josep Nomdedeu

  87. Frequent inactivation of thep73gene by abnormal methylation or LOH in non-Hodgkin's lymphomas

    Article • International Journal of Cancer, September 2002, Wiley

    Josep Nomdedeu

  88. Invisible mycosis fungoides: A diagnostic challenge

    Article • Journal of the American Academy of Dermatology, August 2002, Elsevier

    Josep Nomdedeu

  89. Clonal Heterogeneity Assessed by Flow Cytometry in B-Cell Lymphomas Arising From Germinal Centers

    Article • American Journal of Clinical Pathology, June 2002, Oxford University Press (OUP)

    Josep Nomdedeu

  90. Descripción de una nueva mutación germinal en el gen TP53 en una familia con síndrome de Li-Fraumeni. Asesoramiento clínico a los portadores sanos

    Article • Medicina Clínica, January 2002, Elsevier

    Josep Nomdedeu

  91. Flow cytometry using the monoclonal antibody CD10-Pe/Cy5 is a useful tool to identify follicular lymphoma cells

    Article • European Journal Of Haematology, February 2001, Wiley

    Josep Nomdedeu

  92. Quantitative Detection of AML1-ETO Rearrangement by Real-Time RT-PCR Using Fluorescently Labeled Probes

    Article • Leukemia & Lymphoma, January 2001, Taylor & Francis

    Josep Nomdedeu

  93. Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia

    Article • Bone Marrow Transplantation, January 2001, Springer Science + Business Media

    Josep Nomdedeu

  94. Typical CBFβ/MYH11 fusion due to insertion of the 3′-MYH11 gene into 16q22 in acute monocytic leukemia with normal chromosomes 16 and trisomies 8 and 22

    Article • Cancer Genetics and Cytogenetics, December 2000, Elsevier

    Josep Nomdedeu

  95. CD66 expression in acute leukaemia

    Article • Annals of Hematology, June 2000, Springer Science + Business Media

    Josep Nomdedeu

  96. Invisible mycosis fungoides: A diagnostic challenge

    Article • Journal of the American Academy of Dermatology, February 2000, Elsevier

    Josep Nomdedeu

  97. Flow cytometric detection of B cell abnormal maturation in chronic myeloid leukemia

    Article • Leukemia, January 2000, Springer Science + Business Media

    Josep Nomdedeu

  98. Análisis mutacional de p53 en la leucemia linfoblástica T

    Article • Medicina Clínica, January 2000, Elsevier

    Josep Nomdedeu

  99. Adult de novo acute myeloid leukemias with MLL rearrangements

    Article • Leukemia Research, June 1999, Elsevier

    Josep Nomdedeu

  100. Prevalence of hemochromatosis related HFE gene mutations in patients with acute myeloid leukemia

    Article • Leukemia Research, June 1999, Elsevier

    Josep Nomdedeu

  101. Enhanced myeloid specificity of CD 117 compared with CD13 and CD33

    Article • Leukemia Research, April 1999, Elsevier

    Josep Nomdedeu

  102. True

    Article • Leukemia, January 1999, Springer Science + Business Media

    Josep Nomdedeu

  103. cCD79a expression in a case of plasma cell leukemia

    Article • Leukemia Research, July 1998, Elsevier

    Josep Nomdedeu

  104. Concomitant chronic lymphocytic leukemia and acute myeloid leukemia with an uncommon immunophenotype

    Article • American Journal of Hematology, December 1997, Wiley

    Josep Nomdedeu

  105. Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia

    Article • Genes Chromosomes and Cancer, August 1997, Wiley

    Josep Nomdedeu

  106. Distribution ofTP53 mutations among acute leukemias withMLL rearrangements

    Article • Genes Chromosomes and Cancer, January 1996, Wiley

    Josep Nomdedeu

  107. Two new variants of RAG‐1 protein predicted by SSCP

    Article • Human Mutation, January 1996, Wiley

    Josep Nomdedeu

  108. Genetic analysis of chromosome 13 deletions inBCR/ABL negative chronic myeloproliferative disorders

    Article • Genes Chromosomes and Cancer, October 1995, Wiley

    Josep Nomdedeu

  109. Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation

    Article • American Journal of Hematology, May 1994, Wiley

    Josep Nomdedeu

  110. Aggressive natural killer cell leukaemia/lymphoma in two patients with lethal midline granuloma

    Article • British Journal of Haematology, March 1994, Wiley

    Josep Nomdedeu

  111. Successful Treatment of Pneumonia Due to Scedosporium apiospermum with Itraconazole: Case Report

    Article • Clinical Infectious Diseases, May 1993, Oxford University Press (OUP)

    Josep Nomdedeu

  112. MOPP, ABVD, or Both to Treat Hodgkin's Disease

    Article • New England Journal of Medicine, April 1993, New England Journal of Medicine (NEJM/MMS)

    Josep Nomdedeu